Overview of Spasmalgon
| Property | Description |
|---|---|
| Active Ingredient | Sodium Metamizole, Fenpiverinium Bromide, Pitofenone |
| Form | Tablets, Solution for Injection |
| Pharmacological Class | Analgesic and Antispasmodic Combination |
| General Purpose | Relief of pain associated with smooth muscle spasm |
| Origin | Synthetic Small Molecule Derivatives |
Spasmalgon is a synthetic, fixed-dose combination medicinal product, principally classified as an analgesic and antispasmodic preparation. Its design is engineered for concurrent action against pain and the underlying smooth muscle spasms that cause it. Clinical experience indicates that this medicine provides potent relief primarily through its ability to powerfully diminish pain sensation.
What Type of Medicine is Spasmalgon?
Spasmalgon is a combination preparation that simultaneously addresses both pain and involuntary muscle contractions. This analgesic and antispasmodic classification signifies its dual therapeutic intent: to reduce the perception of pain while actively relieving the excessive tension in smooth muscles. The medicine is based on synthetic small molecule derivatives, reflecting its origin through chemical synthesis.
Spasmalgon's Triple-Action Composition and Forms
The medication's unique profile is derived from the precise blend of three active ingredients. These include the non-opioid analgesic Sodium Metamizole, combined with two distinct smooth muscle relaxants: the M-cholinoblocker Fenpiverinium Bromide and the myotropic spasmolytic Pitofenone. This synergistic blend is manufactured in two primary dosage forms: tablets for oral administration and a solution for injection for parenteral administration. The availability of both forms allows for flexible application depending on the required speed and setting of administration.
What is the General Purpose of Combining these Ingredients?
The primary therapeutic purpose of combining these ingredients is to achieve comprehensive relief from pain associated with involuntary muscle cramps or excessive smooth muscle tension. This formulation integrates potent pain reduction (analgesia) with a dual mechanism of muscle relaxation (spasmolysis). This general benefit defines the medication's utility in managing spasms that arise from the smooth muscle organs, such as the urinary, biliary, or gastrointestinal tracts. For instance, it is typically used for the acute, severe discomfort felt during the passage of kidney or gallbladder stones.
Regulatory References
